ALN-HTT02
ALN-HTT02-001
Phase 1 small_molecule active
Quick answer
ALN-HTT02 for Huntington's Disease is a Phase 1 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Huntington's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active